NCT06930937View on ClinicalTrials.gov

To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

October 25, 2024

Study Completion Date

November 11, 2024

Conditions
Prevention of Stroke or Systemic EmbolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)
Interventions
OTHER

Lixiana® Film Coated Tablet

Lixiana® 60 mg filmtabletten (Film Coated Tablet) (Edoxaban)

OTHER

Edoxaban Film Coated Tablet

Edoxaban 60 mg Film Coated Tablet

Trial Locations (1)

382210

Cliantha Research Limited, Ahmedabad

All Listed Sponsors
lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06930937 - To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film Coated Tablet) (Edoxaban) in Healthy, Adult, Human Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter